A share price of Sarepta Therapeutics Inc [SRPT] is currently trading at $17.98, up 4.11%. An important factor to consider is whether the stock is rising or falling in short-term value. The SRPT shares have gain 10.99% over the last week, with a monthly amount drifted -18.12%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sarepta Therapeutics Inc [NASDAQ: SRPT] stock has seen the most recent analyst activity on November 05, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $26 for it. Previously, BMO Capital Markets upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $50. On July 29, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $37 on the stock. JP Morgan upgraded its rating to a Neutral but stick to its price target of $24 on July 29, 2025. Barclays upgraded its rating to a Equal Weight but $22 remained the price target by the analyst firm on July 29, 2025. H.C. Wainwright reiterated a Sell rating for this stock on July 29, 2025, but kept the price target unchanged to $5. In a note dated July 29, 2025, Bernstein initiated an Mkt Perform rating and provided a target price of $13 on this stock.
Sarepta Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $10.41 and $138.81. Currently, Wall Street analysts expect the stock to reach $25.9 within the next 12 months. Sarepta Therapeutics Inc [NASDAQ: SRPT] shares were valued at $17.98 at the most recent close of the market. An investor can expect a potential return of 44.05% based on the average SRPT price forecast.
Analyzing the SRPT fundamentals
Trailing Twelve Months sales for Sarepta Therapeutics Inc [NASDAQ:SRPT] were 2.41B which represents -14.52% decline. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.1%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.2 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.15 points at the first support level, and at 16.33 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.55, and for the 2nd resistance point, it is at 19.13.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sarepta Therapeutics Inc [NASDAQ:SRPT] is 2.95. On the other hand, the Quick Ratio is 1.78, and the Cash Ratio is 0.67. Considering the valuation of this stock, the price to sales ratio is 0.78, the price to book ratio is 1.43.
Transactions by insiders
Recent insider trading involved Sarepta Therapeutics, Inc., Shareholder, that happened on Aug 13 ’25 when 9.27 million shares were purchased. Director, Nicaise Claude completed a deal on Mar 12 ’25 to sell 2491.0 shares. Meanwhile, Director Nicaise Claude bought 2491.0 shares on Mar 12 ’25.
